biosimilaaristen
Biosimilaaristen, often referred to as biosimilars, are biological medicines that are highly similar to an already approved biological medicine, known as the reference product. They are not exact copies but are designed to have no clinically meaningful differences in terms of safety, quality, and efficacy. Biological medicines are complex molecules derived from living organisms, unlike small-molecule drugs which are chemically synthesized. This complexity means that creating an exact replica is not possible.
The development of biosimilars involves rigorous scientific and regulatory processes to demonstrate this similarity. Regulatory agencies,
The availability of biosimilars can increase competition in the market, potentially leading to lower healthcare costs.